News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Jingchuan Zhang

Articles by Jingchuan Zhang

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer

ByRavi K. Goyal,Jingchuan Zhang,Samina Dhuliawala,Martina Sluga-O’Callaghan,Peter A. Kaufman, MD

April 18th 2022

Latest Updated Articles

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer
Published: April 18th 2022 | Updated:

Trending on CancerNetwork

Fecal Microbiota Transplantation Shows Feasibility in Metastatic RCC

Neoadjuvant Pembrolizumab Yields High pCR Rate in Desmoplastic Melanoma

New ASCO Guideline Offers Recommendations for Smoldering Multiple Myeloma

Reducing Secondary Diagnostic Delay Through the Breast Clinical Reporting and Data System

Indirect Comparison Supports Zanubrutinib Monotherapy in CLL/SLL Care